TAP Pharmaceutical Products Incorporation announced that it has submitted a New Drug Application (NDA) with the United States Food and Drug Administration (FDA) for Febuxostat 80 mg and 120 mg for the management of hyperuricemia in patients with chronic gout.
Hyperuricemia, elevated uric acid levels in the body, is related with gout, a painful type of arthritis. Febuxostat, an oral, once-daily medication, is a novel non-purine, selective inhibitor of xanthine oxidase studied for its e...
| Currently you cannot purchase Febuxostate as it might be not available for sale online or on local pharmacy. Subscribe below and we will inform you where and when you can order Febuxostate |
| Febuxostate Availability Subscription Form |
|
| |
| Note: We will email you when Febuxostate is available for sale online or in pharmacy in your country. |
|
|
|
|